Amarin Corp Plc (AMRN)

[Whalatane]

Hamoa. re your view

As a check on the overall investment thesis here, and setting aside the recent US litigation drama, I would just ask yourself what you think the global market for icosapent ethyl will be in 5 years. Then calculate what you think Amarin's share of that market will be. Then consider today's valuation of Amarin.

When thinking about the global market ....understand how expensive Amarin's brand Vascepa is in other markets if not covered by govt insurance plans.

Pharmadude has already stated that Vascepa retails for $400 CAD a month ...in Canada and there is NO govt insurance coverage because their govt feels that Amarin has over priced Vascepa by 43% based on their cost / benefit analysis .
Same will occur in the EU ......there is no " global market " of any size for Vascepa as currently priced by AMRN .

To achieve a market in at least the wealthy" western "countries where govt controlled health coverage is dominant ....AMRN needs to strip costs and lower their price for Vascepa to confirm with those govt cost/ benefit analysis .

I'm waiting to see how they plan to do that .
Kiwi